![]() |
|
|
Fast Track
My Amedeo
FAQ
About
|
|
|||||||||
| FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology |
|
| Parkinson's Disease |
|
Free Subscription
1 Ann Pharmacother |
Retrieve available abstracts of this week’s articles:
HTML format Text format |
| Single Articles |
Efficacy and Safety of Deep Brain Stimulation as an Adjunct to Pharmacotherapy
for the Treatment of Parkinson Disease (February).
Ann Pharmacother. 2012.
PubMed
Text format
Related articles
Abstract available
Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a
Reduced Parkinson Disease Risk.
Arch Neurol. 2012;69:105-10.
PubMed
Text format
Related articles
Abstract available
Microtubule affinity regulating kinase 2 (MARK2) turns PTEN-induced kinase 1
(PINK1) on at T313, a mutation site in Parkinson's disease: Effects on
mitochondrial transport.
J Biol Chem. 2012.
PubMed
Text format
Related articles
Abstract available
Development of Parkinson's disease in patients with Narcolepsy.
J Neural Transm. 2012.
PubMed
Text format
Related articles
Abstract available
Changes of hand preference in Parkinson's disease.
J Neural Transm. 2012.
PubMed
Text format
Related articles
Abstract available
Subcortical white matter hyperintensities within the cholinergic pathways of
Parkinson's disease patients according to cognitive status.
J Neurol Neurosurg Psychiatry. 2012.
PubMed
Text format
Related articles
Abstract available
Visual hallucinations in the differential diagnosis of parkinsonism.
J Neurol Neurosurg Psychiatry. 2012.
PubMed
Text format
Related articles
Abstract available
L-DOPA Impairs Proteasome Activity in Parkinsonism through D1 Dopamine Receptor.
J Neurosci. 2012;32:681-91.
PubMed
Text format
Related articles
Abstract available
Action reprogramming in Parkinson's disease: response to prediction error is
modulated by levels of dopamine.
J Neurosci. 2012;32:542-50.
PubMed
Text format
Related articles
Abstract available
Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome
study.
Mov Disord. 2012 Jan 11. doi: 10.1002/mds.24892.
PubMed
Text format
Related articles
Abstract available
No correlation of substantia nigra echogenicity and nigrostriatal degradation in
Parkinson's disease.
Mov Disord. 2012 Jan 11. doi: 10.1002/mds.24070.
PubMed
Text format
Related articles
Abstract available
Apathy in parkinson's disease: Diagnostic and etiological dilemmas.
Mov Disord. 2012 Jan 11. doi: 10.1002/mds.24061.
PubMed
Text format
Related articles
Abstract available
Prevalence of pain in Parkinson's disease: A systematic review using the modified
QUADAS tool.
Mov Disord. 2012 Jan 9. doi: 10.1002/mds.24054.
PubMed
Text format
Related articles
Abstract available
Evidence of an association between the scavenger receptor class B member 2 gene
and Parkinson's disease.
Mov Disord. 2012 Jan 5. doi: 10.1002/mds.24886.
PubMed
Text format
Related articles
Abstract available
Taking sides: Is handedness involved in motor asymmetry of Parkinson's disease?
Mov Disord. 2012 Jan 5. doi: 10.1002/mds.24048.
PubMed
Text format
Related articles

Animal models of the non-motor features of Parkinson's disease.
Neurobiol Dis. 2012.
PubMed
Text format
Related articles
Abstract available
Use of viral vectors to create animal models for Parkinson's disease.
Neurobiol Dis. 2011.
PubMed
Text format
Related articles
Abstract available
Is levodopa toxic? Insights from a brain bank.
Neurology. 2011;77:1414-5.
PubMed
Text format
Related articles

Selective attention deficits in early and moderate stage Parkinson's disease.
Neurosci Lett. 2011.
PubMed
Text format
Related articles
Abstract available
Thank you for your interest in scientific medicine.
This service is provided by AMEDEO through an unrestricted educational grant from Boehringer Ingelheim.
Amedeo is a
Flying Publisher website.